×

Omnicell Shares Outstanding 2010-2024 | OMCL

Omnicell shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Omnicell Annual Shares Outstanding
(Millions of Shares)
2024 46
2023 45
2022 46
2021 48
2020 44
2019 43
2018 41
2017 39
2016 37
2015 37
2014 37
2013 36
2012 34
2011 34
2010 34
2009 32
Omnicell Quarterly Shares Outstanding
(Millions of Shares)
2024-12-31 46
2024-09-30 46
2024-06-30 46
2024-03-31 46
2023-12-31 45
2023-09-30 46
2023-06-30 45
2023-03-31 45
2022-12-31 46
2022-09-30 46
2022-06-30 46
2022-03-31 48
2021-12-31 48
2021-09-30 48
2021-06-30 47
2021-03-31 46
2020-12-31 44
2020-09-30 44
2020-06-30 43
2020-03-31 44
2019-12-31 43
2019-09-30 43
2019-06-30 43
2019-03-31 42
2018-12-31 41
2018-09-30 41
2018-06-30 40
2018-03-31 40
2017-12-31 39
2017-09-30 39
2017-06-30 38
2017-03-31 37
2016-12-31 37
2016-09-30 37
2016-06-30 36
2016-03-31 36
2015-12-31 37
2015-09-30 37
2015-06-30 37
2015-03-31 37
2014-12-31 37
2014-09-30 37
2014-06-30 37
2014-03-31 36
2013-12-31 36
2013-09-30 36
2013-06-30 35
2013-03-31 35
2012-12-31 34
2012-09-30 34
2012-06-30 34
2012-03-31 34
2011-12-31 34
2011-09-30 34
2011-06-30 34
2011-03-31 34
2010-12-31 34
2010-09-30 34
2010-06-30 33
2010-03-31 33
2009-12-31 32
2009-09-30 32
2009-06-30 32
2009-03-31 31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.845B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $36.709B 54.09
Hims & Hers Health (HIMS) United States $11.210B 183.25
Tempus AI (TEM) United States $10.954B 0.00
Inspire Medical Systems (INSP) United States $5.532B 107.78
IRhythm Technologies (IRTC) United States $3.734B 0.00
Privia Health (PRVA) United States $2.941B 245.10
Enovis (ENOV) United States $2.475B 16.49
Clover Health Investments (CLOV) United States $2.095B 0.00
Azenta (AZTA) United States $2.083B 96.98
Schrodinger (SDGR) United States $1.580B 0.00
Phreesia (PHR) United States $1.577B 0.00
10x Genomics (TXG) United States $1.381B 0.00
Butterfly Network (BFLY) United States $0.859B 0.00
Fulgent Genetics (FLGT) United States $0.512B 0.00
Standard BioTools (LAB) United States $0.495B 0.00
Talkspace (TALK) United States $0.481B 285.00
TruBridge (TBRG) United States $0.423B 123.26
Nyxoah SA (NYXH) Belgium $0.353B 0.00
Pulmonx (LUNG) United States $0.352B 0.00
Health Catalyst (HCAT) United States $0.305B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.257B 0.00
American Well (AMWL) United States $0.174B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
MDxHealth SA (MDXH) Belgium $0.085B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
111 (YI) China $0.072B 0.00
CareCloud (CCLD) United States $0.054B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.034B 0.00
Movano (MOVE) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Precipio (PRPO) United States $0.014B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00